<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES/HYPOTHESIS: Epstein-Barr virus (EBV) has classically been associated with nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, multiple studies have been published linking EBV with oral <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> and, to a lesser extent, hypopharyngeal and <z:e sem="disease" ids="C0023055" disease_type="Neoplastic Process" abbrv="">laryngeal tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Using a sensitive method of detection, the authors sought to analyze the presence and quantity of EBV DNA in a large cohort of <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>STUDY DESIGN: : Retrospective cohort study </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Three hundred <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancer</z:e> samples exclusive of nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> were examined for the presence of EBV using quantitative polymerase chain reaction </plain></SENT>
<SENT sid="5" pm="."><plain>Eighty-four <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples from the larynx, 30 from the hypopharynx, 73 from the oropharynx, and 113 from the oral cavity were analyzed for EBV quantity, which was expressed as the number of <z:mp ids='MP_0001799'>viral</z:mp> copies per cell genome </plain></SENT>
<SENT sid="6" pm="."><plain>Representative samples, which contained the highest EBV DNA levels, were examined using in situ hybridization </plain></SENT>
<SENT sid="7" pm="."><plain>Results were correlated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grade and site and tobacco and alcohol exposure </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Three of 300 (1%) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples were overtly positive for EBV DNA (defined as &gt;0.1 copies of <z:mp ids='MP_0001799'>viral</z:mp> DNA/cell genome) </plain></SENT>
<SENT sid="9" pm="."><plain>Five of 300 (2%) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples showed low levels (defined as &gt;0.01 and &lt;0.1 copies of <z:mp ids='MP_0001799'>viral</z:mp> DNA/cell genome), and 68 of 300 tumor samples (23%) showed trace levels (defined as &lt; 0.01 copies of <z:mp ids='MP_0001799'>viral</z:mp> DNA/cell genome) of EBV DNA </plain></SENT>
<SENT sid="10" pm="."><plain>No correlation was found between EBV positivity and tobacco exposure, alcohol exposure, or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grade </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: In the overwhelming majority of <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e> in this North American cohort, EBV did not appear to contribute to growth of a dominant clonal population with integrated EBV genome and was unlikely to be a genetic etiological agent in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development </plain></SENT>
<SENT sid="12" pm="."><plain>The low quantities of EBV detected in a minority of <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e> may be related to the presence of EBV genome in rare lymphoid or epithelial cells adjacent to the primary <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancer</z:e> </plain></SENT>
</text></document>